(Q52970124)

10 May 2018

title

Double-blind cross-over evaluation of mazindol in the treatment of obese hypertensive patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A792640

28 July 2022

0 references

P. J. Miach

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A792640

28 July 2022

W. Thomson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A792640

28 July 2022

A. E. Doyle

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A792640

28 July 2022

W. J. Louis

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A792640

28 July 2022

language of work or name

English

0 references

publication date

1 September 1976

1 reference

10 May 2018

4 September 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=792640

Medical Journal of Australia

28 July 2022

published in

1 reference

10 May 2018

volume

2

1 reference

10 May 2018

issue

10

1 reference

10 May 2018

page(s)

378-380

1 reference

10 May 2018

10.5694/J.1326-5377.1976.TB130259.X

Identifiers

DOI

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=792640

28 July 2022

1 reference

10 May 2018